SEC Filing

View:

SEC FORM 3 SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Rennick Gavin

(Last)

(First)

(Middle)

5599 SAN FELIPE, 17TH FLOOR

(Street)

HOUSTON

77056

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/08/2019

3. Issuer Name and Ticker or Trading Symbol
SCHLUMBERGER LIMITED/NV [ SLB ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
VP, Human Resources

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, $0.01 Par Value Per Share	705	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Incentive Stock Option (Right to Buy)	⁽¹⁾	01/16/2024	Common Stock, $0.01 Par Value Per Share	5,630	88.765	D
Incentive Stock Option (Right to Buy)	04/16/2020	04/16/2025	Common Stock, $0.01 Par Value Per Share	1,000	91.74	D
Incentive Stock Option (Right to Buy)	10/15/2020	10/15/2025	Common Stock, $0.01 Par Value Per Share	110	75.075	D
Incentive Stock Option (Right to Buy)	04/20/2021	04/20/2026	Common Stock, $0.01 Par Value Per Share	1,241	80.525	D
Incentive Stock Option (Right to Buy)	01/19/2022	01/19/2027	Common Stock, $0.01 Par Value Per Share	1,144	87.38	D
Non-Qualified Stock Option (Right to Buy)	01/21/2015	01/21/2020	Common Stock, $0.01 Par Value Per Share	1,200	68.505	D
Non-Qualified Stock Option (Right to Buy)	⁽²⁾	01/20/2021	Common Stock, $0.01 Par Value Per Share	5,000	83.885	D
Non-Qualified Stock Option (Right to Buy)	⁽³⁾	01/19/2022	Common Stock, $0.01 Par Value Per Share	4,000	72.11	D
Non-Qualified Stock Option (Right to Buy)	⁽⁴⁾	04/18/2023	Common Stock, $0.01 Par Value Per Share	5,000	70.925	D
Non-Qualified Stock Option (Right to Buy)	⁽⁵⁾	01/16/2024	Common Stock, $0.01 Par Value Per Share	2,370	88.765	D
Non-Qualified Stock Option (Right to Buy)	⁽⁶⁾	04/16/2025	Common Stock, $0.01 Par Value Per Share	4,000	91.74	D
Non-Qualified Stock Option (Right to Buy)	⁽⁷⁾	10/15/2025	Common Stock, $0.01 Par Value Per Share	9,890	75.075	D
Non-Qualified Stock Option (Right to Buy)	⁽⁸⁾	04/20/2026	Common Stock, $0.01 Par Value Per Share	18,759	80.525	D
Non-Qualified Stock Option (Right to Buy)	⁽⁹⁾	01/19/2027	Common Stock, $0.01 Par Value Per Share	23,856	87.38	D
Non-Qualified Stock Option (Right to Buy)	⁽¹⁰⁾	01/17/2028	Common Stock, $0.01 Par Value Per Share	11,490	77.1	D
Non-Qualified Stock Option (Right to Buy)	⁽¹¹⁾	01/16/2029	Common Stock, $0.01 Par Value Per Share	25,810	41.47	D
RSU (Restricted Stock Unit)	⁽¹²⁾	⁽¹²⁾	Common Stock, $0.01 Par Value Per Share	6,200	⁽¹³⁾	D
RSU (Restricted Stock Unit)	⁽¹⁴⁾	⁽¹⁴⁾	Common Stock, $0.01 Par Value Per Share	4,210	⁽¹³⁾	D
RSU (Restricted Stock Unit)	⁽¹⁵⁾	⁽¹⁵⁾	Common Stock, $0.01 Par Value Per Share	6,720	⁽¹³⁾	D

Explanation of Responses:

1. This option became exercisable in five equal annual installments beginning January 16, 2015, of 1,126 shares.

2. This option became exercisable in five equal annual installments beginning January 20, 2012, of 1,000 shares.

3. This option exercisable in five equal annual installments beginning January 19, 2013, of 800 shares.

4. This option became exercisable in five equal annual installments beginning April 18, 2014, of 1,000 shares.

5. This option became exercisable in five equal annual installments beginning January 16, 2015, of 474 shares.

6. This option became exercisable in three equal annual installments beginning April 16, 2016, of 1,000 shares and becomes exercisable in a final installment of 1,000 shares on April 16, 2019.

7. This option became exercisable in four equal annual installments of 2,000 shares beginning October 15, 2016, and a final installment of 1,890 shares on October 15, 2020.

8. This option became exercisable in four equal annual installments of 4,000 shares beginning April 20, 2017, and a final installment of 2,759 shares on April 20, 2021.

9. This option became exercisable in four equal annual installments of 5,000 shares beginning January 19, 2018, and a final installment of 3,856 shares on January 19, 2022.

10. This option became exercisable in five equal annual installments of 2,298 shares beginning January 17, 2019.

11. This option becomes exercisable in five annual installments of 5,162 shares beginning January 16, 2020.

12. The restricted stock unit award was granted on January 19, 2017 and vests 100% on January 19, 2020.

13. Each restricted stock unit represents the right to receive, at settlement, one (1) share of common stock.

14. The restricted stock unit award was granted on January 17, 2018 and vests 100% on January 17, 2021.

15. The restricted stock unit award was granted on January 16, 2019 and vests 100% on January 16, 2022.

	/s/ Grace B. Holmes, Attorney-in-Fact	02/19/2019
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

SCHLUMBERGER LIMITED POWER OF ATTORNEY

       The undersigned, in his capacity as a director or
officer, or both, of Schlumberger Limited, a Curacao
corporation (the "Company"), does hereby appoint each of
Saul Laureles, Matthew Rinegar and Grace Holmes, or
any of them acting singly, his true and lawful attorney-
in-fact with full power of substitution, to (a) prepare,
execute in the undersigneds name and on the undersigneds
behalf, and submit to the U.S. Securities and Exchange
Commission (the "SEC") a Form ID, including amendments
thereto, and any other documents necessary or appropriate
to obtain codes, passwords and passphrases enabling the
undersigned to make electronic filings with the SEC
of reports required by Section 16(a) of the Securities
Exchange Act of 1934, as amended (the Exchange Act), or
any rule or regulation of the SEC; and (b) execute for
and on behalf of the undersigned, in the undersigneds
capacity as a director or officer, or both, of the Company,
Forms 3, 4 and 5 in accordance with Section 16 of the
Exchange Act, as well as Forms 144, and complete and
execute any amendment or amendments thereto, and to file
the same or cause the same to be filed with the SEC.
       This Power of Attorney supersedes any and all
prior and existing powers of attorney signed by the
undersigned with respect to the subject matter hereof, and
shall remain in full force and effect until the undersigned
is no longer required to file Forms 3, 4, 5 or 144 with
respect to the undersigneds holdings of and transactions
in securities issued by the Company, unless earlier revoked
by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

February 8, 2019

/s/ Gavin Rennick
Gavin Rennick